NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma

Folia Histochemica et Cytobiologica

Volumn 47, Issue 2, 2009, Pages 249-255

  Olakowski, Marek ^a   Tyszkiewicz, Tomasz ^b   Jarza̧b, Michał ^b   Król, Robert ^a   Oczko Wojciechowska, Małgorzata ^b   Kowalska, Małgorzata ^b   Kowal, Monika ^b   Gala, Grzegorz M ^b   Kajor, Maciej ^a   Lange, Dariusz ^b   Chmielik, Ewa ^b   Gubala, Elzbieta ^b   Lampe, Paweł ^a   Jarza̧b, Barbara ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Anillin (ANLN) gene; NBL1 gene; Oligonucleotide microarrays; Pancreatic cancer; Real time quantitative PCR

Indexed keywords

ACTIN BINDING PROTEIN; ANILLIN; CALCIUM BINDING PROTEIN; MOLECULAR MARKER; NEUROBLASTOMA SUPPRESSION OF TUMORIGENICITY 1; PROTEIN; RNA; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE OVEREXPRESSION; HUMAN; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PRINCIPAL COMPONENT ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

EID: 73549117910     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0031-1     Document Type: Article

References (34)

1. Schneider G, Siveke JT, Eckel F, Schmid RM. Pancreatic cancer: basic and clinical aspects. Gastroenterology. 2005;128(6):1606-1625.
2. Grutzmann R, Boriss H, Ammerpohl O, Luttges J, Kalthoff H, Schackert HK et al. Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene. 2005;24(32):5079-5088.
3. Chelala C, Hahn SA, Whiteman HJ, Barry S, Hariharan D, Radon TP et al. Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets. BMC Genomics. 2007;8:439.
4. Garcea G, Neal CP, Pattenden CJ, Steward WP, Berry DP. Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer. 2005;41(15):2213-2236.
5. Wettenhall JM, Smyth GK. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 2004;20(18):3705-3706.
6. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA et al. Accurate normalization of real-time quantitative RTPCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.
7. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003;63(10):2649-2657.
8. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR et al. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res. 2007;67(18):8633-8642.
9. Ohuchida K, Mizumoto K, Egami T, Yamaguchi H, Fujii K, Konomi H et al. S100P is an early developmental marker of pancreatic carcinogenesis. Clin Cancer Res. 2006;12(18):5411-5416.
10. Deng H, Shi J, Wilkerson M, Meschter S, Dupree W, Lin F. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens. Am J Clin Pathol. 2008;129(1):81-88.
11. Lin F, Shi J, Liu H, Hull ME, Dupree W, Prichard JW et al. Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis. Am J Surg Pathol. 2008;32(1):78-91.
12. Hickson GR, O'Farrell PH. Anillin: a pivotal organizer of the cytokinetic machinery. Biochem Soc Trans. 2008;36(Pt 3):439-441.
13. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A. 2003;100(10):5974-5979.
14. Moreno-Bueno G, Sanchez-Estevez C, Cassia R, Rodriguez-Perales S, az-Uriarte R, Dominguez O et al. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res. 2003;63(18):5697-5702.
15. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 2003;14(8):3208-3215.
16. Hall PA, Todd CB, Hyland PL, McDade SS, Grabsch H, Dattani M et al. The septin-binding protein anillin is overexpressed in diverse human tumors. Clin Cancer Res. 2005;11(19 Pt 1):6780-6786.
17. Suzuki C, Daigo Y, Ishikawa N, Kato T, Hayama S, Ito T et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 2005;65(24):11314-11325.
18. Kikuchi T, Daigo Y, Katagiri T, Tsunoda T, Okada K, Kakiuchi S et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene. 2003;22(14):2192-2205.
19. Piekny AJ, Glotzer M. Anillin is a scaffold protein that links RhoA, actin, and myosin during cytokinesis. Curr Biol. 2008;18(1):30-36.
20. Skrzypski M, Jassem E, Taron M, Sanchez JJ, Mendez P, Rzyman W et al. Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Clin Cancer Res. 2008;14(15):4794-4799.
21. Ozaki T, Sakiyama S. Tumor-suppressive activity of N03 gene product in v-src-transformed rat 3Y1 fibroblasts. Cancer Res. 1994;54(3):646-648.
22. Enomoto H, Ozaki T, Takahashi E, Nomura N, Tabata S, Takahashi H et al. Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus. Oncogene. 1994;9(10):2785-2791.
23. Nakamura Y, Ozaki T, Ichimiya S, Nakagawara A, Sakiyama S. Ectopic expression of DAN enhances the retinoic acid-induced neuronal differentiation in human neuroblastoma cell lines. Biochem Biophys Res Commun. 1998;243(3):722-726.
24. Hanaoka E, Ozaki T, Nakamura Y, Moriya H, Nakagawara A, Sakiyama S. Overexpression of DAN causes a growth suppression in p53-deficient SAOS-2 cells. Biochem Biophys Res Commun. 2000;278(1):20-26.
25. Shinbo J, Ozaki T, Nakagawa T, Watanabe K, Nakamura Y, Yamazaki M et al. p73-dependent expression of DAN during cisplatin-induced cell death and osteoblast differentiation. Biochem Biophys Res Commun. 2002;295(2):501-507.
26. Kim AS, Pleasure SJ. Expression of the BMP antagonist Dan during murine forebrain development. Brain Res Dev Brain Res. 2003;145(1):159-162.
27. Lopez de MR, Martin B, Millar RP, Brown P, Davidson L, Pawson AJ et al. GnRH-mediated DAN production regulates the transcription of the GnRH receptor in gonadotrope cells. Neuromolecular Med. 2007;9(3):230-248.
28. Chen B, Blair DG, Plisov S, Vasiliev G, Perantoni AO, Chen Q et al. Cutting edge: bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with Slits and act as negative regulators of monocyte chemotaxis. J Immunol. 2004;173(10):5914-5917.
29. Ohtori S, Yamamoto T, Ino H, Hanaoka E, Shinbo J, Ozaki T et al. Differential screening-selected gene aberrative in neuroblastoma protein modulates inflammatory pain in the spinal dorsal horn. Neuroscience. 2002;110(3):579-586.
30. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A. 1995;92(12):5520-5524.
31. Fujita T, Igarashi J, Okawa ER, Gotoh T, Manne J, Kolla V et al. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas. J Natl Cancer Inst. 2008;100(13):940-949.
32. Okawa ER, Gotoh T, Manne J, Igarashi J, Fujita T, Silverman KA et al. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas. Oncogene. 2008;27(6):803-810.
33. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 2003;162(4):1151- 1162.
34. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res. 2003;63(24):8614- 8622.